KY, C., Y, C., J, S., CM, C., PS, P., & HM, L. (2026). GLP-1 Receptor Agonist Use and Survival Among Patients With Type 2 Diabetes and Brain Metastases. JAMA network open, 9(3), e261311. https://doi.org/10.1001/jamanetworkopen.2026.1311
Chicago Style (17th ed.) CitationKY, Chi, Chang Y, Song J, Chen CM, Perng PS, and Lin HM. "GLP-1 Receptor Agonist Use and Survival Among Patients With Type 2 Diabetes and Brain Metastases." JAMA Network Open 9, no. 3 (2026): e261311. https://doi.org/10.1001/jamanetworkopen.2026.1311.
MLA (9th ed.) CitationKY, Chi, et al. "GLP-1 Receptor Agonist Use and Survival Among Patients With Type 2 Diabetes and Brain Metastases." JAMA Network Open, vol. 9, no. 3, 2026, p. e261311, https://doi.org/10.1001/jamanetworkopen.2026.1311.